JNJ 303

CAS No. 878489-28-2

JNJ 303( —— )

Catalog No. M20998 CAS No. 878489-28-2

JNJ 303 is a potent blocker of IKs (IC50 : 64 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 53 Get Quote
5MG 82 Get Quote
10MG 135 Get Quote
25MG 309 Get Quote
50MG 447 Get Quote
100MG 668 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    JNJ 303
  • Note
    Research use only, not for human use.
  • Brief Description
    JNJ 303 is a potent blocker of IKs (IC50 : 64 nM).
  • Description
    JNJ 303 is a potent blocker of IKs (IC50 : 64 nM).
  • In Vitro
    JNJ 303 can block IKs with an IC50 value of 64 nM. JNJ 303 (3.3 μM) does not have any effects on other cardiac channels.JNJ 303 induces QT-prolongations and causes unprovoked torsades de pointes (TdP).
  • In Vivo
    JNJ 303 recapitulates the Exn4-induced decrease in fasting blood glucose level in mice.
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    IKs
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    878489-28-2
  • Formula Weight
    440.98
  • Molecular Formula
    C21H29ClN2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 62.5 mg/mL (141.73 mM)
  • SMILES
    CC(C)(Oc1ccc(Cl)cc1)C(=O)NC1C2CC3CC1CC(NS(C)(=O)=O)(C3)C2
  • Chemical Name
    2-(4-Chloro-phenoxy)-N-(5-methanesulfonylamino-adamantan-2-yl)-2-methyl-propionamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kang C Badiceanu A Brennan J A et al. β-adrenergic stimulation augments transmural dispersion of repolarization via modulation of delayed rectifier currents IKs and IKr in the human ventricle[J]. Scientific Reports 2017 7(1):15922.
molnova catalog
related products
  • KCNQ1 activator-1?

    2-Piperidinecarboxamide, N-[4-(4-methoxyphenyl)-2-thiazolyl]-1-(phenylsulfonyl)- is a potent KCNQ1 channel activator that can be used in long QT syndrome (LQTS) studies.

  • Clofilium tosylate

    Clofilium tosylate is a potassium channel blocker, induces apoptosis on human promyelocytic leukemia (HL-60) cells.

  • TRAM 39

    TRAM 39 is a selective blocker of intermediate-conductance Ca2+-activated K+channels.